Siav — M&A Activity 2026

Mar 4, 2026

SIAV

INFO SOCIETÀ BENEFIT

PRESS RELEASE

SIAV ACCELERATES IN DIGITAL HEALTHCARE THROUGH THE ACQUISITION OF THE "DOCUMENT MANAGEMENT" BUSINESS UNIT

Implementation of corporate reorganisation plan continues, strengthening recurring revenues and industrial synergies

Rubano (PD), 4 March 2026 - Siav S.p.A. Società Benefit (the "Company" or "SIAV") leader in Italy in the Enterprise Content Management sector, listed on the Euronext Growth Milan (EGM) market, announces that it has today completed the sale of its 20.54% stake in Consis Società Consortile a responsabilità limitata. ("Consis"), consortium active in public administration, healthcare and health, with products and services in the field of ICT, information systems, consulting and training, to Consis Group S.r.l. ("Consis Group"), parent company of Consis (the "Disposal"). At the same time, the Company acquired from Consis the business unit relating to document management activities in the public health sector. (the "Acquisition", in conjunction with the Disposal the "Operation").

The transaction is part of a broader corporate reorganisation process that SIAV continues to pursue, in line with its strategy of focusing on its core business and positioning itself in segments with higher added value, with a view to strengthening operational efficiency

Methods and details of the Operation

The Disposal carried out by SIAV, concerning the entire stake held in Consis, equal to 20.54%, was made in favour of Consis Group for a consideration of €521,600. The price includes a payment of €21,600 today and the payment of €500,000 deferred in five equal instalments, due in March 2027.

At the same time, SIAV completed the Acquisition of the Consis business unit responsible for the development, maintenance and marketing of software solutions in the document management sector, including the executive contracts activated under the CONSIP SD1, SD2 and SD3 Framework Agreements. Under the agreements between the parties, the purchase price was set at €1,300,000. The transaction will be settled immediately through the full offsetting of outstanding trade receivables between the companies involved.

The transaction was therefore completed without any negative impact on the Company's cash flow: on the one hand, SIAV received a total of €521,600 from the sale; on the other hand, the acquisition will not involve any outlay, thanks to the offsetting of trade receivables.

The acquired business unit is an organised and functionally autonomous operating unit and, as of January 2026, includes a portfolio of 21 active executive contracts with a remaining duration of up to 48 months, all of which commenced in 2025 and are currently in the execution phase. The contracting authorities include leading Local Health Authorities (ASST), Health Protection Agencies (ATS),

Siav S.p.A. Società Benefit

Via Rossi, 5/n 35030 - Rubano (Padova) - ITALY tel. +39 049 897 9797 info@siav.it siav@pec.siav.it www.siav.it

C.F./P.I.: 02334550288 Capitale Sociale 306.800,91€ Registro Imprese di Padova - REA PD - 223442

Filiali Milano / Bologna / Roma Aziende del Gruppo Siav / Siav Connect FZE / Credit Service

---

SIAV

University Hospitals and IRCCS distributed across several Italian regions. With the completion of the Acquisition, SIAV takes over the contracts, ensuring full operational continuity for the Administrations.

In addition to the above-mentioned contracts, the transferred perimeter includes intellectual property rights to software, technical know-how, databases and existing employment relationships, while debts arising prior to the effective date of the Transfer are expressly excluded.

Strategic rationale for the Operation

The transaction is consistent with SIAV's selective growth strategy, which is geared towards:

• strengthen direct oversight in the digital healthcare segment, characterised by multi-year public contracts and high visibility of flows;
• increase revenue quality by directly taking over relations with contracting authorities;
• improve working capital management through direct control of the accounts receivable cycle;
• integrate proprietary technological assets with cross-selling potential on the Group's current customer base;
• streamline the Group's participatory structure, concentrating resources and skills on activities with greater added value.

The digital healthcare sector, also in light of recent investment trends in the digitisation of administrative and clinical processes, data interoperability and regulatory compliance, continues to represent an area of high resilience and growth prospects. In this scenario, strengthening direct oversight of active and multi-year CONSIP contracts consolidates SIAV's competitive position and enhances its institutional credibility with public clients.

Nicola Voltan, CEO of SIAV, commented: "With this transaction we consolidate our positioning in digital health and strengthen the quality of our contract portfolio. The financial structure of the agreement, which does not involve cash outlay for the acquisition of the business, reflects a rigorous approach to capital allocation and oriented towards the creation of sustainable value in the medium to long term".

The Transaction does not qualify as a significant transaction pursuant to art. 12 of the Euronext Growth Milan Issuers' Regulation.

---

This press release is available in the Investor Relations/Financial Press Releases section of the www.siav.com/it website and on www.1info.it.

---

Siav S.p.A. Società Benefit, established in 1989 in Rubano (PD), is a leader in the Enterprise Content Management (ECM) and Business Process Outsourcing (BPO) sector. Since 2021, the Issuer has assumed the status of Benefit Corporation. The Company is at the top of an international group, active in particular on the Italian market, and has offices in Padua, Milan, Genoa, Bologna and Rome; it also operates in Switzerland and Romania. As of December 31, 2021, the Group boasts over 4,000 active customers, direct and indirect, both private and related to the public administration, to whom an offer is provided divided into three segments: (i) proprietary software for document management (Archiflow, Silloge and Catflow), (ii) proprietary software and vertical solutions related to document management (MyCreditService, SAP dashboards and

www.siav.it
pagina 2 di 3

---

siav

solutions dedicated to the healthcare world); (iii) outsourced professional services (dematerialization and B2B electronic invoicing). As of December 31, 2024, the Group achieved, at a consolidated level, revenues from sales and services of Euro 33.3 million and EBITDA of Euro 6.3 million.

Contacts

Investor Relation

Siav S.p.A. | Daniele Boggian - Investor Relations Manager | investors@siav.it | T: +39 0498979797 | Via A. Rossi 5/n - 35030 Rubano (PD)

IR & Media Relations Advisor

My Twin Communication S.r.l.

Twin

siav@mytwincommunication.com

Mara Di Giorgio | T: +39 335 7737417

Federico Bagatella | T. +39 331 8007258

Euronext Growth Advisor & Specialist

Integrae SIM S.p.A. | info@integraesim.it | T: +39 02 80506160 | Piazza Castello, 24 - 20121 Milano

www.siav.it
pagina 3 di 3